Biofrontera, Inc. (BFRI)
1.53
-0.03
(-1.92%)
USD |
NASDAQ |
Sep 09, 16:00
1.54
+0.01
(+0.65%)
After-Hours: 16:28
Biofrontera Total Assets (Quarterly) : 24.06M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 24.06M |
| March 31, 2026 | 24.79M |
| December 31, 2025 | 28.56M |
| September 30, 2025 | 15.42M |
| June 30, 2025 | 20.14M |
| March 31, 2025 | 16.59M |
| December 31, 2024 | 22.10M |
| September 30, 2024 | 18.52M |
| June 30, 2024 | 21.57M |
| March 31, 2024 | 24.58M |
| December 31, 2023 | 27.93M |
| Date | Value |
|---|---|
| September 30, 2023 | 34.10M |
| June 30, 2023 | 36.90M |
| March 31, 2023 | 41.96M |
| December 31, 2022 | 50.88M |
| September 30, 2022 | 55.06M |
| June 30, 2022 | 53.63M |
| March 31, 2022 | 49.20M |
| December 31, 2021 | 53.22M |
| September 30, 2021 | 15.35M |
| June 30, 2021 | 17.70M |
| March 31, 2021 | 20.80M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 1.494B |
| Corcept Therapeutics, Inc. | 888.70M |
| Veru, Inc. | 37.03M |
| Johnson & Johnson | 201.06B |
| Eli Lilly & Co. | 142.28B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 18.11M |
| Shareholders Equity (Quarterly) | 5.956M |
| Debt to Equity Ratio | 1.260 |
| Current Ratio | 1.180 |
| Net Debt Paydown Yield | -3.93% |